BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tessitore A, Gaggiano A, Cicciarelli G, Verzella D, Capece D, Fischietti M, Zazzeroni F, Alesse E. Serum biomarkers identification by mass spectrometry in high-mortality tumors. Int J Proteomics 2013;2013:125858. [PMID: 23401773 DOI: 10.1155/2013/125858] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Ciocan-Cartita CA, Jurj A, Buse M, Gulei D, Braicu C, Raduly L, Cojocneanu R, Pruteanu LL, Iuga CA, Coza O, Berindan-Neagoe I. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics". Int J Mol Sci 2019;20:E2576. [PMID: 31130665 DOI: 10.3390/ijms20102576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
2 Jimenez-Luna C, Torres C, Ortiz R, Dieguez C, Martinez-Galan J, Melguizo C, Prados JC, Caba O. Proteomic biomarkers in body fluids associated with pancreatic cancer. Oncotarget. 2018;9:16573-16587. [PMID: 29662668 DOI: 10.18632/oncotarget.24654] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
3 Kira S, Mitsui T, Miyamoto T, Ihara T, Nakagomi H, Hashimoto Y, Takamatsu H, Tanahashi M, Takeda M, Sawada N, Andersson K, Takeda M. Liquid chromatography–mass spectrometry identification of serum biomarkers for nocturia in aged men. World J Urol 2019;37:2199-205. [DOI: 10.1007/s00345-019-02647-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kimura Y, Yanagimachi M, Ino Y, Aketagawa M, Matsuo M, Okayama A, Shimizu H, Oba K, Morioka I, Imagawa T, Kaneko T, Yokota S, Hirano H, Mori M. Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis. Sci Rep 2017;7:43732. [PMID: 28262744 DOI: 10.1038/srep43732] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
5 Leow CH, Fischer K, Leow CY, Cheng Q, Chuah C, McCarthy J. Single Domain Antibodies as New Biomarker Detectors. Diagnostics (Basel) 2017;7:E52. [PMID: 29039819 DOI: 10.3390/diagnostics7040052] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
6 Li B, Li B, Guo T, Sun Z, Li X, Li X, Wang H, Chen W, Chen P, Qiao M, Xia L, Mao Y. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors. Med Sci Monit 2017;23:1636-44. [PMID: 28376075 DOI: 10.12659/msm.901064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
7 Chuffa LGA, Lupi Júnior LA, Seiva FRF, Martinez M, Domeniconi RF, Pinheiro PFF, dos Santos LD, Martinez FE. Quantitative Proteomic Profiling Reveals That Diverse Metabolic Pathways Are Influenced by Melatonin in an in Vivo Model of Ovarian Carcinoma. J Proteome Res 2016;15:3872-82. [DOI: 10.1021/acs.jproteome.6b00713] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
8 Toss A, De Matteis E, Rossi E, Casa LD, Iannone A, Federico M, Cortesi L. Ovarian cancer: can proteomics give new insights for therapy and diagnosis? Int J Mol Sci 2013;14:8271-90. [PMID: 23591842 DOI: 10.3390/ijms14048271] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
9 Yılmaz EP, Kumtepe Y. Endometrial and Ovarian Cancer with MR Imaging Importance of Serum HE4 and CA 125 Levels in the Extent of Disease at Evaluation. Eurasian J Med 2016;48:192-8. [PMID: 28149145 DOI: 10.5152/eurasianjmed.2016.0259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Park GW, Kim JY, Hwang H, Lee JY, Ahn YH, Lee HK, Ji ES, Kim KH, Jeong HK, Yun KN, Kim YS, Ko JH, An HJ, Kim JH, Paik YK, Yoo JS. Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation. Sci Rep 2016;6:21175. [PMID: 26883985 DOI: 10.1038/srep21175] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 9.7] [Reference Citation Analysis]
11 Di Minno A, Gelzo M, Caterino M, Costanzo M, Ruoppolo M, Castaldo G. Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine. Int J Mol Sci 2022;23:5213. [PMID: 35563604 DOI: 10.3390/ijms23095213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lancrajan I, Schneider-Stock R, Naschberger E, Schellerer VS, Stürzl M, Enz R. Absolute quantification of DcR3 and GDF15 from human serum by LC-ESI MS. J Cell Mol Med 2015;19:1656-71. [PMID: 25823874 DOI: 10.1111/jcmm.12540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
13 Liu K, Lai M, Wang S, Zheng K, Xie S, Wang X. Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer. Biomed Res Int 2020;2020:6107865. [PMID: 32337262 DOI: 10.1155/2020/6107865] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Bonnier F, Blasco H, Wasselet C, Brachet G, Respaud R, Carvalho LFCS, Bertrand D, Baker MJ, Byrne HJ, Chourpa I. Ultra-filtration of human serum for improved quantitative analysis of low molecular weight biomarkers using ATR-IR spectroscopy. Analyst 2017;142:1285-98. [DOI: 10.1039/c6an01888b] [Cited by in Crossref: 38] [Cited by in F6Publishing: 4] [Article Influence: 7.6] [Reference Citation Analysis]
15 Zamay TN, Zamay GS, Kolovskaya OS, Zukov RA, Petrova MM, Gargaun A, Berezovski MV, Kichkailo AS. Current and Prospective Protein Biomarkers of Lung Cancer. Cancers (Basel) 2017;9:E155. [PMID: 29137182 DOI: 10.3390/cancers9110155] [Cited by in Crossref: 63] [Cited by in F6Publishing: 38] [Article Influence: 12.6] [Reference Citation Analysis]
16 Mukherjee S, Sundfeldt K, Borrebaeck CAK, Jakobsson ME. Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers. Proteomes 2021;9:25. [PMID: 34070600 DOI: 10.3390/proteomes9020025] [Reference Citation Analysis]
17 Harvey DJ. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2013-2014: ANALYSIS OF CARBOHYDRATES AND GLYCOCONJUGATES. Mass Spec Rev 2018;37:353-491. [DOI: 10.1002/mas.21530] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
18 Ansari D, Andersson R, Bauden MP, Andersson B, Connolly JB, Welinder C, Sasor A, Marko-Varga G. Protein deep sequencing applied to biobank samples from patients with pancreatic cancer. J Cancer Res Clin Oncol. 2015;141:369-380. [PMID: 25216700 DOI: 10.1007/s00432-014-1817-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
19 Júnior LAL, Cucielo MS, Domeniconi RF, Dos Santos LD, Silveira HS, da Silva Nunes I, Martinez M, Martinez FE, Fávaro WJ, Chuffa LGA. P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study. ACS Omega 2019;4:21761-77. [PMID: 31891054 DOI: 10.1021/acsomega.9b02512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Bonnier F, Brachet G, Duong R, Sojinrin T, Respaud R, Aubrey N, Baker MJ, Byrne HJ, Chourpa I. Screening the low molecular weight fraction of human serum using ATR-IR spectroscopy. J Biophoton 2016;9:1085-97. [DOI: 10.1002/jbio.201600015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
21 Kim H, Lim M, Kim JY, Shin SJ, Cho YK, Cho CH. Circulating Tumor Cells Enumerated by a Centrifugal Microfluidic Device as a Predictive Marker for Monitoring Ovarian Cancer Treatment: A Pilot Study. Diagnostics (Basel) 2020;10:E249. [PMID: 32340330 DOI: 10.3390/diagnostics10040249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Trivedi DK, Hollywood KA, Goodacre R. Metabolomics for the masses: The future of metabolomics in a personalized world. New Horiz Transl Med 2017;3:294-305. [PMID: 29094062 DOI: 10.1016/j.nhtm.2017.06.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 57] [Article Influence: 8.8] [Reference Citation Analysis]